VaxGen Forms Joint Venture to Build Manufacturing Facilities in California and South Korea
Facilities Designed to Support Potential Regulatory Approval and Commercial Manufacture of VaxGen's AIDS Vaccine
27-Feb-2002 -
BRISBANE, Calif. and SEOUL – February 25, 2002 – VaxGen, Inc. and a group of South Korean investors today announced the formation of a joint venture, which will invest approximately $120 million to build and operate a facility in Incheon, South Korea, to manufacture VaxGen’s AIDS vaccine. The ...
AIDS
biologics
bioreactors
+6